The Board of Trustees of the Leland Stanford Junior University
发明人:
Robert Lowsky,Edgar George Engleman,Samuel Strober
申请号：
US16716102
公开号：
US20200164195A1
申请日:
2019.12.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Residual, refractory or relapsed cancer is treated by immunostimulation in the presence of allogeneic immune effector cells, optimally in combination with radiation therapy. The methods of the disclosure induce a systemic allogeneic anti-tumor immune response that results in tumor regression in untreated sites of disease, i.e. non-injected, non-irradiated, etc.
